Dico Technologies Srl was founded in 2021, with the aim of enabling the communication of patients who cannot speak and have movement limitations.
Our mission is to give a voice to the voiceless, thanks to communication solutions based on advanced and user-friendly digital technologies for the patient and their caregivers. For this reason, we have created DICo®1000, an innovative device in the field of Augmentative Alternative Communication (AAC).
The company is included in the register of Innovative Start-ups, thanks to the high technological value proposed and the qualification of its founders. The know-how is proprietary and protected by an Italian Industrial Invention Patent, extended internationally. Our technological solutions are developed and manufactured entirely in Italy, with a high standard of quality, reliability and safety.
Dico Technologies responds to an extremely important need, still without specific effective solutions, and in order to quickly spread its proposal to the market, it is open to getting in touch with industrial and research partners, to foster innovation and growth in Italy and abroad.
Founders
Aldo Padova
CEO & Co-Founder
Chemical Engineer & MBA SDA Bocconi, Expert in management consulting and business management.
Giacomo Bellani
Scientific Advisor & Co-Founder
Full Professor of Anesthesia and Intensive Care University of Trento, passionate about clinical research and teaching.
Operating Team
Ruggero Di Maulo
COO & Regulatory Affairs
Engineer & MBA Politecnico di Milano, Tech Startup development and Digital Healthcare Transformation Expert.
Paolo Bartoli
Marketing & Sales
M.Sc. at Bocconi University , marketing and business development expert in pharmaceutical and consumer healthcare markets.
Riccardo Monti
Product Specialist
Biomedical Engineer, Full Stack developer with digital technologies DNA.
Kevin Covini
Product Developer
IT Engineer, Full stack developer with specific skills in machine learning & Al.
Commercial Partners
DICo®1000
For the hospital distribution of the DICo®1000 device in intensive and sub-intensive care departments and in ordinary hospitalizations, Dico Technologies has signed a commercial partnership with SEDA S.p.A, a leading distributor in Italy of medical products and equipment.
“This agreement is a great opportunity as it allows us to make our value proposition known and at the same time enables SEDA to enrich its offer of innovative solutions” underlines Aldo Luciano Padova, CEO of DICO Technologies.
Established in 1973 and specializing in the fields of cardiac surgery, cardiology, anesthesia and resuscitation and general surgery, SEDA has always placed, alongside and beyond its commercial purpose, the best protection of patients’ health, through the introduction of new, more effective techniques, validated with the scientific assistance provided by the medical profession in order to fully demonstrate their clinical advantages and the opportunity for their use in our country.
The introduction of innovative techniques and constant scientific support for the best use of high-quality devices are the basis of our service. Throughout our history we have always worked to best satisfy the needs of our customers. We firmly believe that the quality of a service or product does not lie in the effort used to guarantee it but in what the customer gets from it. Therefore, for us, maintaining high quality standards is equivalent to best protecting the work of healthcare professionals and therefore the health of patients.
50 years of experience as sellers of medical products, medical devices and medical equipment, researched and selected by the best companies in the sector, are the confirmation of our professionalism and the ability to always put product safety and customer satisfaction first. All products sold comply with EU Regulation 2017/745 on Medical Devices and have passed rigorous tests by our internal regulatory department.
DICo®XpM
For home care needs, the DICo®XpM device is distributed by Nippon Gases Pharma, a leading company in the supply of systems and services in the healthcare sector, with a high specialization in solutions for Homecare and home and outpatient care services for patients undergoing respiratory therapies, and offers integrated care with latest-generation digital solutions.
Nippon Gases Pharma S.r.l. is the company of the Nippon Gases Group, which deals with hospital and home services for the healthcare sector.
Founded in Turin in 1920 with the name “Rivoira”, today it is part of Nippon Gases Europe.
Nippon Gases Pharma S.r.l. is responsible for enhancing and promoting the national market of medicinal gases, medical devices and equipment in the hospital and territorial sector. Nippon Gases Pharma has solid and important experience in the field of home care for people affected by chronic disabling diseases. In particular, it offers a variety of home services that allow the provision of long-term therapies, such as mechanical ventilation, management of sleep disorders and home respiratory care.
The introduction of innovative techniques and constant scientific support for the best use of high-quality devices are the basis of our service. Throughout our history we have always worked to best satisfy the needs of our customers. We firmly believe that the quality of a service or product does not lie in the effort used to guarantee it but in what the customer gets from it. Therefore, for us, maintaining high quality standards is equivalent to best protecting the work of healthcare professionals and therefore the health of patients.
In compliance with the European Pharmacopoeia, the company markets real drugs with Marketing Authorization (AIC). In this way, it guarantees the maximum effectiveness of the gases supplied in the therapeutic field, ensuring quality and safety for patients and for the operators of the facilities. Nippon Gases Pharma also designs and manufactures centralized medicinal gas distribution systems in accordance with the UNI EN ISO 13485:2016 quality system.
Technical Partners
UNGUESS
UNGUESS was born with a clear vision: to involve users in the design and development process of digital products, to help improve the world we live in.
We support companies in making strategic decisions based on data, thanks to solutions that integrate: an advanced technological platform, a crowd of real, engaged and profiled users, and cutting-edge research and testing methodologies. In this way, we offer the possibility of collecting insights and feedback directly from end users, concretely improving the experience and quality of digital products.
VTT
VTT is a visionary research, development and innovation partner for companies and society, and one of the leading technical research organisations in Europe.
With more than 2,300 employees, we have over 80 years of experience in cutting-edge research and science-based results. We promise to always think beyond the obvious.
